Skip to content

The effect of depth of anesthesia on pain after surgery

The effect of depth of anesthesia on pain after surgery in laparascopic cholesystectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017011412642N25
Enrollment
60
Registered
2017-01-24
Start date
2016-09-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

general anesthesia. Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

Interventions

Intervention 1: In the first group (L group) after induction of anesthesia, anesthesia in order to maintain BIS between 35 and 45, propofol with dose of 75 to 150 micrograms per kilogram of body weigh
Prevention
In the first group (L group) after induction of anesthesia, anesthesia in order to maintain BIS between 35 and 45, propofol with dose of 75 to 150 micrograms per kilogram of body weight and remifentan
In the first group (H group) after induction of anesthesia, anesthesia in order to maintain BIS between 35 and 45, propofol with dose of 75 to 150 micrograms per kilogram of body weight and remifentan

Sponsors

Vice chancellor for research, Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patient candidated for elective laparascopic cholesystectomy; patient with ASA I or II; Lack of malignancy or seizures; Lack of auditory problem; BMI<35; Lack of heart, pulmonary, liver and kidney failure; Lack of uncontrolled systemic disease; Lack of addiction; Lack of chronic pain and/or with any analgesic drug.Exclusion criteria: Prolongation of action for more than three hours; Conversion of laparoscopic surgery to laparotomy; patient death.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Heart rate. Timepoint: during surgery, before and after that. Method of measurement: with pulse oxymeter device and according to beat per minute.;Need to analgesic drug. Timepoint: during 24 hours after surgery. Method of measurement: according to miligeram.;Amount of pain. Timepoint: in recovery and 8,16 and 24hours after surgery. Method of measurement: with using of VAS score.;Systolic and diastolic blood pressure. Timepoint: during surgery, before and after that. Method of measurement: Non-invasive barometer in mm Hg.

Secondary

MeasureTime frame
Amount of nausea and vomitting. Timepoint: during 24 hours after surgery. Method of measurement: according to severity and score 0 to 3.;Duration of surgery. Timepoint: from start of surgery to start of recovery. Method of measurement: according to minute.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPoopak Rahimzadeh

Anesthesiology group of Iran University of Medical Science

p-rahimzadeh@tums.ac.ir+98 21 6651 5001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026